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ABSTRACT 26 
The Charm MRL Beta-Lactam and Tetracycline test (Charm MRL BLTET test. Charm 27 
Sciences Inc., Lawrence, MA) is an immunoreceptor assay utilizing ROSA
®
 (Rapid 28 
One Step Assay) lateral flow technology that detects beta-lactam and/or tetracycline 29 
drugs in raw commingled cow milk at or below EU-MRLs. The Charm MRL BLTET 30 
test procedure was recently modified (dilution in buffer and longer incubation) by the 31 
manufacturers to be used with raw ewe`s and goat’s milk. In order to assess the Charm 32 
MRL BLTET test for the detection of beta-lactams and tetracyclines in milk of small 33 
ruminants, an evaluation study was performed at Instituto de Ciencia y Tecnologia 34 
Animal (ICTA) of Universitat Politècnica de València (Spain). The test specificity and 35 
detection capability (CCβ) were studied following Commission Decision 2002/657/EC. 36 
Specificity results obtained in this study were optimal for individual milk free of 37 
antimicrobials from ewes (99.2 % for beta-lactams and 100 % for tetracyclines) and 38 
goats (97.9 % for beta-lactams and 100 % for tetracyclines) along the entire lactation 39 
period regardless of whether the results were visually or instrumentally interpreted. 40 
Moreover, no positive results were obtained when a relatively high concentration of 41 
different substances belonging to antimicrobial families other than beta-lactams and 42 
tetracyclines were present in ewe’s and goat’s milk. For both types of milk, the CCβ 43 
calculated was lower or equal to EU-MRL for amoxicillin (4 µg.Kg
-1
), ampicillin (4 44 
µg.Kg
-1
), benzylpenicillin (≤ 2 µg.Kg-1), dicloxacillin (30 µg.Kg-1), oxacillin (30 µg.Kg-45 
1
), cefacetrile (≤ 63 µg.Kg-1), cefalonium (≤ 10 µg.Kg-1), cefapirin (≤ 30 µg.Kg-1), 46 
desacetylcefapirin (≤ 30 µg.Kg-1), cefazolin (≤ 25 µg.Kg-1), cefoperazone (≤ 25 µg.Kg-47 
1
), cefquinome (20 µg.Kg
-1
), ceftiofur (≤ 50 µg.Kg-1), desfuroylceftiofur (≤ 50 µg.Kg-1) 48 
and cephalexin (≤ 50 µg.Kg-1). However, this test could neither detect cloxacillin nor 49 
nafcillin at or below EU-MRL (CCβ > 30 µg.Kg-1). The CCβ for tetracyclines was also 50 
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lower than EU-MRL for chlortetracycline (ewe’s milk: ≤ 50 µg.Kg-1 and goat’s milk: 75 51 
µg.Kg
-1
), oxytetracycline (≤ 50 µg.Kg-1) and tetracycline (≤ 50 µg.Kg-1). Regarding the 52 
4-epimers of these tetracyclines only 4-epioxytetracycline was detected by the Charm 53 
MRL BLTET test below EU-MRL (ewe’s milk: 75 µg.Kg-1 and goat’s milk: ≤ 50 54 
µg.Kg
-1
). Acidiol had no effect on the performance of the test. The Charm MRL BLTET 55 
test could be used routinely with adapted test procedure for the fast screening of ewe’s 56 
and goat’s milk. 57 
Keywords: ewe and goat milk, antibiotic, receptor binding assay, ROSA Charm 58 
INTRODUCTION 59 
In dairy ewes and goats, just as in dairy cows, treatment of mastitis and other infectious 60 
diseases with pharmacological products is a standard practice. In many cases, antibiotic 61 
milk contamination may be caused by treatments carried out without a veterinary 62 
prescription and with inadequate knowledge of the suitable dosage, administration route 63 
or depletion time of the antibiotic substance (Molina et al., 2003a). This is partly due to 64 
the fact that there are very few drugs on the market specifically authorised for the use in 65 
lactating small ruminants, particularly goats, and occasionally veterinarians can 66 
prescribe drugs under ‘cascade’. Due to inter-species differences, available bovine data 67 
cannot be accurately extrapolated for the use in the dairy ewes and goats (Pengor and 68 
Kirbis, 2009). 69 
Drug residues in milk supplies may not only have public health implications (Phillips et 70 
al., 2004; Sanders et al., 2011) but may also interfere in the manufacture of dairy 71 
products such as cheeses and yoghurts (Packham et al., 2001; Berruga et al., 2011). 72 
In some Mediterranean countries such as Spain, France, Italy and Greece, the 73 
production of ewe’s and goat’s milk plays a prominent role because of tradition and 74 
successful commercialization into products such as different cheeses and yoghurt 75 
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(Haenlein, 2001). For this reason, milk quality is mainly evaluated in terms of its 76 
technological or coagulation properties which can be affected by the presence of 77 
antibiotic residues in milk. 78 
To avoid risks related to drug residues, the control of the presence of veterinary 79 
medicinal products in foodstuffs of animal origin at different stages of the production 80 
process is legally binding in many countries. The US Food and Drug Administration 81 
Center for Veterinary Medicine (FDA) established Safe Levels/Tolerance of antibiotic 82 
residues in milk for the consumer protection (FDA, 2005). In the European Union, the 83 
regulatory levels or Maximum Residue Limits (EU-MRLs) are defined by Regulation 84 
(EC) 470/2009 (European Union, 2009) and established by Commission Regulation 85 
(EU) 37/2010 (European Union, 2010). 86 
Currently, numerous screening tests are commercially available to detect all kinds of 87 
antibiotics in milk (IDF, 2010). Choosing a test depends on the control step (farms, 88 
dairies or laboratories) and on the antibiotics used in the area of milk production. In 89 
farms and dairies, receptor binding assays are most commonly applied due to their 90 
simple and fast response. These methods, based on the use of specific receptors to detect 91 
antibiotics, were originally designed for the swift detection of beta-lactam antibiotics in 92 
cow’s milk (Charm and Zomer, 1995). Along recent years these tests have been further 93 
developed, and there are currently specific receptor binding assays available for the 94 
detection of various antimicrobials such as tetracyclines, gentamicin, enrofloxacin or 95 
sulfonamides. Improvements made have also been directed at the reduction of the 96 
analysis period required and the inclusion of different receptors in one test type, having 97 
resulted in combined tests capable of detecting various groups of antibiotics 98 
simultaneously. 99 
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The Charm MRL Beta-Lactam and Tetracycline test (Charm Sciences Inc., Lawrence, 100 
MA) is an immunoreceptor assay utilizing ROSA
®
 (Rapid One Step Assay) lateral flow 101 
technology that detects beta-lactam and/or tetracycline drugs in raw commingled cow 102 
milk at or below EU-MRLs. This test is widely used for screening cow’s milk, and the 103 
test procedure was recently modified by the manufacturers to be used with raw milk 104 
from ewes and goats. 105 
In order to assess the Charm MRL BLTET test for the detection of beta-lactams and 106 
tetracyclines in milk of small ruminants, an evaluation study was performed at Instituto 107 
de Ciencia y Tecnologia Animal (ICTA) of Universitat Politècnica de València (Spain). 108 
The test specificity and detection capability (CCβ) were studied following Commission 109 
Decision 2002/657/EC (European Union, 2002). 110 
MATERIAL AND METHODS 111 
Milk samples 112 
In order to obtain antibiotic-free milk samples along the entire lactation period, the 113 
experimental flocks of Manchega ewes of Universidad de Castilla-La Mancha 114 
(Albacete, Spain) and Murciano-Granadina goats of Universitat Politècnica de València 115 
(Valencia, Spain) were used. Animals had a good health status and did not receive any 116 
veterinary treatment neither before nor during the experimental period. 117 
Test specificity. 118 
Commission Decision 2002/657/EC (European Union, 2002) describes specificity as the 119 
ability of a method to distinguish between the analyte being measured and other related 120 
substances including the matrix constituents. According to this EC Regulation 121 
specificity for the Charm MRL BLTET test was investigated using two approaches: the 122 
false-positive rate was calculated when antibiotic-free milk samples were analyzed, and 123 
the study of possible interferences related to the presence of substances belonging to 124 
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antimicrobial families other than beta-lactams and tetracyclines in milk samples (cross-125 
reaction) was carried out. 126 
To calculate the false-positive rate of the Charm MRL BLTET test individual milk 127 
samples (200 mL) from 25 ewes and 25 goats were collected fortnightly along the entire 128 
lactation period. Ewe’s milk samples were obtained at the morning milking from the 129 
first week after weaning until the end of lactation (5 months). Goat’s milk was collected 130 
from the second week postpartum during a period of seven months. 131 
Milk samples were analyzed using MilkoScan 6000 (Foss, Hillerd, Denmark) to 132 
determine their chemical composition (fat, protein and total solids); SCC (somatic cell 133 
count) was obtained using Fossomatic 5000 (Foss, Hillerd, Denmark); BC (bacterial 134 
count) was determined using Bactoscan FC (Foss, Hillerd, Denmark) and the pH value 135 
was measured by a conventional pHmeter (Crison, Barcelona, Spain). 136 
Antibiotic-free milk samples (n=250 for ewes and n=350 for goats) were tested 137 
employing the Charm MRL BLTET test to assess the test specificity with each species. 138 
Samples giving positive results were retested (three replicates). Only samples showing 139 
positive results in at least two replicate analyses were classified as positive. Specificity 140 
was calculated as the percentage of negative samples with respect to the total of samples 141 
analyzed.  142 
To check for interferences related to antimicrobial substances other than beta-lactams 143 
and tetracyclines (cross-reaction), 20 individual raw milk samples free of 144 
antimicrobials, 10 for ewes and 10 for goats, were collected in the mid-lactation period. 145 
Milk samples were spiked individually with a relatively high concentration of different 146 
drugs and analyzed by Charm MRL BLTET test. In agreement with Reybroeck et al. 147 
(2010), the drug concentration in milk samples was 10xEU-MRL, and one substance 148 
was chosen from each of the most important groups of antimicrobials: neomycin 149 
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(aminoglycosides), lincomycin (lincosamides), erythromycin (macrolides), colistin 150 
(polimyxins), enrofloxacin (quinolones) and sulfadiazine (sulfonamides). 151 
Detection Capability (CCβ) 152 
The International Dairy Federation (IDF, 2002) establishes the requirements for the 153 
milk samples selected for use as “negative milk” in the evaluation studies of screening 154 
tests for antibiotics detection. These requirements have been established only for cow's 155 
milk. However, if a test is applied for milk of an animal species other than cows, the 156 
requirements with respect to the status of the animal should be adjusted accordingly. 157 
Individual milk samples (200 mL) were collected in the mid-lactation period from 40 158 
ewes (more than 60 days and below 90 days postpartum) and 40 goats (more than 90 159 
days and below 150 days postpartum). The samples were refrigerated at 4 ºC and were 160 
analyzed to determine their pH, chemical composition and hygienic quality within 24 h 161 
after milking, using the analytical methods mentioned previously. For Manchega ewes’ 162 
milk, fat content was between 5 % and 9 %, protein between 4.7 % and 8 % and total 163 
solids between 15 % and 22 %. Concerning hygienic quality, somatic cell count was < 164 
300x10
3
 cell.mL
-1
 and bacterial count was < 10
5
 cfu.mL
-1
. The pH value for ewe’s milk 165 
samples was between 6.6 and 6.8. For milk from Murciano-Granadina goats, fat content 166 
was between 3.3 % and 7 %, protein between 3.1 % and 4.7 %, and total solids between 167 
12 % and 17 %. Somatic cell count was < 750 x10
3
 cell.mL
-1
, and bacterial count was < 168 
10
5
 cfu.mL
-1
. The pH value for goats’ milk was between 6.5 and 6.8. 169 
Selected antibiotic-free milk samples were analyzed by the Charm MRL BLTET test, 170 
and the samples giving negative results were spiked with different beta-lactams and 171 
tetracyclines to calculate the detection capability (CCβ) of this test. 172 
Detection capability (CCβ) was calculated according to the “Guidelines for the 173 
validation of screening methods for residues of veterinary medicines” proposed for 174 
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Community Reference Laboratories Residues (CRLs, 2010). This guideline document 175 
supplements Commission Decision 2002/657/EC, and defines CCβ as the concentration 176 
at which only ≤ 5 % false compliant results remain. For authorized analytes, the 177 
concentration at which a screening test categorizes the sample as “screen positive” 178 
(potentially non-compliant) and triggers a confirmatory test is called Screening Target 179 
Concentration (STC) and it must be at or below EU-MRL. If the STC is set at half EU-180 
MRL, the occurrence of one or no false-compliant results following the analysis of at 181 
least 20 “screen positive” control samples is sufficient to demonstrate that CCβ is below 182 
EU-MRL and below or equal to 50 % of EU-MRL. If STC is set between 50 % and 90 183 
% of EU-MRL, at least 40 “screen positive” control samples with no more than 2 false-184 
non compliant results will be sufficient to demonstrate that CCβ is below EU-MRL. If 185 
STC approaches EU-MRL (below 10 % of EU-MRL) a maximum of 60 replicates with 186 
no more than 3 false-non compliant results is required to demonstrate that CCβ is fit for 187 
this purpose. Antibiotic concentrations used for the calculation of the CCβ of the Charm 188 
MRL BLTET test were initially 0.5xEU-MRL (20 replicates); 0.75xEU-MRL (40 189 
replicates) and 1xEU-MRL (60 replicates), respectively, only when necessary. 190 
Effect of preservative acidiol 191 
To evaluate the effect of the preservative acidiol on the response of the Charm MRL 192 
BLTET test, antibiotic-free milk samples from 25 ewes and 25 goats were used. 193 
Individual milk samples were divided into two aliquots; one without preservative and 194 
one with acidiol; and analyzed by the Charm MRL BLTET test. Thereafter, each milk 195 
sample was spiked with benzylpenicillin and oxytetracycline at EU-MRL (4 µg.Kg
-1
 196 
and 100 µg.Kg
-1
, respectively) and analyzed again by the Charm MRL BLTET test. 197 
Acidiol was prepared and used according to the Spanish regulation (Real Decreto 198 
752/2011) which stipulates the composition (0.75 g chloramphenicol, 10 mL ethanol, 18 199 
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g sodium azide, 45 g trisodium citrate 5.5H2O, 0.35 g bromophenol blue, in 1000 mL of 200 
distilled water) and the dosage of this preservative in ewe’s and goat’s milk (133 µl per 201 
40 ml of raw milk). 202 
Antibiotics and spiked milk samples 203 
The antibiotics used in this study were stored and handled according to the 204 
manufacturer’s instructions before use. 205 
Drugs were dissolved (1mg.mL
-1
) in water in a 25 ml volumetric flask at the time when 206 
analyses were carried out. In some cases the use of a small amount of a suitable solvent 207 
was necessary before adding water. Table 1 summarizes antibiotic commercial 208 
references and the solvent employed for the preparation of antibiotic stock solutions. 209 
Spiked milk samples were prepared following the recommendations of the International 210 
Dairy Federation (IDF, 2002) and milk analysis was performed within four hours after 211 
spiking. 212 
Test procedure 213 
The Charm MRL BLTET test (Charm Sciences, Inc., Lawrence, MA) was employed 214 
following the manufacturer’s instructions. For ewes and goats, 300 µl of milk sample 215 
was mixed with 300 µl of the dilution buffer (Sheep milk dilution buffer or Goat milk 216 
dilution buffer, respectively. Charm Sciences, Inc.) and refrigerated for 10 minutes. 217 
Thereafter, 300 µL of the mixture were placed in the sample compartment of the strip 218 
placed in the ROSA Incubator (Charm Sciences, Inc.). The incubation time was set at 219 
56 ºC for 16 minutes (two sets of 8 minutes), and results were interpreted visually by 220 
three trained laboratory technicians and with the ROSA
®
 Reader (ROSA
®
 Pearl Reader. 221 
Charm Sciences, Inc.). 222 
The Charm MRL BLTET test uses receptors that bind beta-lactam and tetracycline 223 
drugs. As milk flows through the test strip, unreacted receptors bind at the BL and/or 224 
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TET position and form a visible reddish test line. A weaker intensity BL or TET line 225 
forms when beta-lactam and/or tetracycline drugs are present in the milk sample. 226 
The visual interpretation of the results was carried out by comparing the BL and TET 227 
lines with the C (control) line. If both lines are darker than or equal to the C line, the 228 
milk sample is negative (antibiotic-free). If either the BL or TET line is lighter than the 229 
C line or the BL or TET line does not form, the sample is positive (likely antibiotic 230 
presence). 231 
The performance of the reader system was checked daily by low and high calibration 232 
strips and by testing negative and positive control standards (benzylpenicillin: 4 µg.Kg
-1 
233 
and oxytetracycline: 100 µg.Kg
-1
; Charm MRL BLTET Positive tablet. Charm Sciences, 234 
Inc.) prior to testing samples. Milk samples giving a reader value ≤ 0 were considered 235 
negative, while milk samples giving a reader value > 0 were considered positive. 236 
Statistical analysis 237 
To assess the effect of the reading system used for the interpretation of the test results 238 
(visual or instrumental) on the test response, a chi-square test was employed. When an 239 
expected frequency was < 5 the Fisher’s exact test was applied. A significant difference 240 
was defined by p < 0.05. Statistical analysis was performed using SAS (version 9.2, 241 
2001; SAS Institute, Inc., Cary, NC). 242 
RESULTS AND DISCUSSION 243 
Test Specificity 244 
Table 2 summarizes the chemical composition and hygienic quality of the individual 245 
milk samples used to assess the false-positive rate of the Charm MRL BLTET test. 246 
Mean milk sample quality parameters were similar to those reported by other authors 247 
for ewe’s (Requena et al., 2010) and goat’s milk (Salama et al., 2003). 248 
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According to the instrumental interpretation (Table 3), specificity of the Charm MRL 249 
BLTET test with adapted assay procedure for the detection of beta-lactam antibiotics 250 
(BL line) was 99.2 % for ewes’ milk (a false-positive rate of 0.8 %) and 97.9 % for 251 
goats’ milk (a false-positive rate of 2.1 %). Specificity was 100 % for the detection of 252 
tetracyclines (TET line) in ewes’ and goats’ milk (no false-positive results). In all cases, 253 
the specificity calculated according to the visual interpretation of the results was slightly 254 
lower than that obtained by the ROSA
®
 Reader, but no statistically significant 255 
differences were found (p > 0.05). 256 
Specificity results obtained in this study were optimal for both types of milk and 257 
indicate that the characteristics of the milk do not influence the test response. The few 258 
goat’s milk samples that were classified as positive (7 false-positive results) had 259 
standard characteristics of the Murciano-Granadina breed. The mean values for the 260 
quality parameters considered were: pH: 6.73, fat: 6.47 %, protein: 4.12 %, total solids: 261 
16.04 %, SCC: 519x10
3
 cell.mL
-1 
and BC: 62x10
3
 cfu.mL
-1
. 262 
There is only a limited number of evaluation studies of receptor binding assays in ewe’s 263 
and goat’s milk available. Reybroeck et al. (2010) for the Betastar (1+1) test (Neogen 264 
Corporation, Lansing, MI) obtained a specificity of 96.8 % for ewes’ milk (1 out of 31 265 
antibiotic-free milk samples) and 96.5 % for goats’ milk (1 out of 29). The same result 266 
(96.7 %) was obtained by Zeng et al. (1998) for the SNAP Betalactam test (IDEXX 267 
Laboratories, Westbrook, ME) using raw commingled goats’ milk (1 out of 30). 268 
Comparing our results with those reported by other authors with different receptor 269 
binding assays from Charm Sciences, Inc. (Lawrence, MA), Berruga et al. (2009) using 270 
the Charm MRL BLTET test in ewe’s milk obtained a lower specificity for the 271 
detection of beta-lactam antibiotics (90 %) and a similar specificity (99 %) for 272 
tetracyclines. Although these authors also used individual ewe’s milk for the evaluation 273 
12 
 
of this test, it must be emphasized that they followed the same procedure recommended 274 
for cow’s milk (no buffer dilution used and incubation time at 56 ºC for 8 minutes) 275 
which could explain the differences observed. 276 
Specificity of the Charm MRL BLTET test obtained in this study with adapted test 277 
procedure for individual goat’s milk (97.4 % and 97.9 % for visual or instrumental 278 
interpretation, respectively) was similar to that found by Reybroeck et al., (2011) using 279 
the beta-lactam screening test Charm MRL-3 test (Charm Sciences, Inc.) with 280 
individual cow’s milk samples (97.6 %). This low false-positive rate (between 2.1 % 281 
and 2.6 %) could be related to the use of individual milk samples, since these same 282 
authors calculated a specificity of 99.3 % when analyzing farm milk samples from 283 
cows. On the contrary, for ewes’ and goats’ milk a high incidence of false-positive 284 
results (10 out of 12 and 6 out of 8, respectively) was obtained, suggesting that the 285 
Charm MRL 3 test is not suitable for the detection of beta-lactam antibiotics in non-cow 286 
milk samples. Also, Salter et al. (2011), indicate for the Charm 3 SL3 β-Lactam test 287 
(Charm Sciences, Inc.) a specificity of 100 % for raw commingled milk from cows. 288 
Regarding the cross-reaction study for the Charm MRL BLTET test, no positive results 289 
were obtained when a relatively high concentration (10xEU-MRL) of different 290 
substances belonging to antimicrobial families other than beta-lactams and tetracyclines 291 
were present in ewe’s and goat’s milk. These results are similar to those found by 292 
Reybroeck et al. (2011) and Salter et al. (2011) who neither found interferences due to 293 
the presence of other non beta-lactam antimicrobials in milk from cows using the 294 
Charm MRL-3 test and Charm 3 SL3 β-Lactam test (Charm Sciences, Inc.), 295 
respectively. 296 
Detection capability (CCβ) 297 
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Detection capability results (CCβ values) of the Charm MRL BLTET with adapted test 298 
procedure for different beta-lactams and tetracyclines in ewe’s and goat’s milk were 299 
evaluated. The CCβ values calculated according to the visual interpretation of the 300 
results were the same as those obtained by the ROSA
®
 Reader and are summarized in 301 
Tables 4 and 5. 302 
For both types of milk, the CCβ calculated was lower than EU-MRL for 303 
benzylpenicillin (≤ 2 µg.Kg-1), cefacetrile (≤ 63 µg.Kg-1), cefalonium (≤ 10 µg.Kg-1), 304 
cefapirin (≤ 30 µg.Kg-1), desacetylcefapirin (≤ 30 µg.Kg-1), cefazolin (≤ 25 µg.Kg-1), 305 
cefoperazone (≤ 25 µg.Kg-1), ceftiofur (≤ 50 µg.Kg-1), desfuroylceftiofur (≤ 50 µg.Kg-1) 306 
and cephalexin (≤ 50 µg.Kg-1). For amoxicillin (4 µg.Kg-1), ampicillin (4 µg.Kg-1), 307 
dicloxacillin (30 µg.Kg
-1
), oxacillin
 
(30 µg.Kg
-1
) and cefquinome (20 µg.Kg
-1
) the 308 
Charm MRL BLTET CCβ was equal to EU-MRL. However, this test could neither 309 
detect cloxacillin nor nafcillin at or below EU-MRL (CCβ > 30 µg.Kg-1). 310 
The CCβ for tetracyclines was also lower than EU-MRL for chlortetracycline (ewe’s 311 
milk: ≤ 50 µg.Kg-1 and goat’s milk: 75 µg.Kg-1), oxytetracycline (≤ 50 µg.Kg-1) and 312 
tetracycline (≤ 50 µg.Kg-1). Regarding the 4-epimers of these tetracyclines, only 4-313 
epioxytetracycline was detected by the Charm MRL BLTET test below EU-MRL 314 
(ewe’s milk: 75 µg.Kg-1 and goat’s milk: ≤ 50 µg.Kg-1). For 4-epichlortetracycline and 315 
4-epitetracycline the CCβs were above EU-MRL (CCβ > 100 µg.Kg-1). 316 
These results (CCβ ≤ EU-MRL) are similar to those obtained by Reybroeck et al. (2011) 317 
using the Charm MRL-3 test (Charm Sciences, Inc.) to detect beta-lactams in cow’s 318 
milk samples; the only exception being cloxacillin which was also detected by these 319 
authors at a concentration below EU-MRL (14 µg.Kg
-1
). Salter et al. (2011) also 320 
obtained appropriate sensitivity with the Charm 3 SL3 β-lactam test (Charm Sciences, 321 
Inc.) according to Safe Level/Tolerance as stipulated by the US FDA (2005).  322 
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Effect of acidiol on the test response 323 
The presence of acidiol in milk samples had no influence on the response of the Charm 324 
MRL BLTET test. All the antibiotic-free milk samples from ewes and goats spiked with 325 
acidiol were clearly negative (Figure 1) regardless of the system used for the 326 
interpretation of the results. No interference was observed neither with milk samples 327 
spiked with benzylpenicillin (4 µg.Kg
-1
) nor with oxytetracycline (100 µg.Kg
-1
) no 328 
matter whether the interpretation of the results was made visually or instrumentally. 329 
So far, there is no study on the influence of preservatives on the performance of the 330 
receptor binding assays for the detection of antibiotics in milk available. Only studies 331 
with microbial inhibitor tests have been carried out as the presence of preservatives may 332 
interfere with the growth of the microorganism in the test, increasing the incidence of 333 
questionable or false-positive results (Molina et al., 2003b). 334 
The results obtained in this study show the suitability of the Charm MRL BLTET test 335 
for the detection of antibiotic residues of beta-lactams and tetracyclines in ewe’s and 336 
goat’s milk. The Charm MRL BLTET test was neither influenced by the distinct 337 
composition of ewe’s and goat’s milk, characterised by an elevated fat and protein 338 
contents when compared to cow’s milk, nor by the high somatic cell count which some 339 
authors related to false positive results in the microbial screening tests (Althaus et al., 340 
2003) and receptor binding assays (Contreras et al., 1997). 341 
These results are of great relevance for ovine and caprine milk quality control programs. 342 
The Charm MRL BLTET test enables the fast and efficient control of antibiotics in 343 
farms and the dairy industry, thus guaranteeing the absence or presence below legally 344 
established EU-MRLs of most beta-lactams and tetracyclines. Moreover, the Charm 345 
MRL BLTET test was not affected by the presence of the preservative acidiol in milk 346 
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samples, which also allows its use in milk quality control laboratories which normally 347 
analyze ewe’s and goat’s milk with acidiol. 348 
The only aspects of the test which could possibly be improved are the test duration (16 349 
minutes), which is relatively long when compared to other protein receptor binding tests 350 
usually applied in cow’s milk (1-9 minutes), and the need to dilute the ewe’s and goat’s 351 
milk samples with a specific buffer before analysis. In this sense, it is worth mentioning 352 
that the manufacturers are currently working on a new version of the Charm MRL 353 
BLTET test that does no require the buffer and with a shorter incubation time taking 354 
advantage of the high specificity and adequacy of receptors used in the ROSA
®
 Charm 355 
technology. 356 
CONCLUSIONS 357 
The Charm MRL BLTET test displays a high specificity for the detection of antibiotics 358 
in ewe’s and goat’s milk with adapted test procedure regardless of whether the 359 
interpretation of the results is carried out visually or instrumentally. The Detection 360 
capability (CCβ values) obtained for the Charm MRL BLTET test indicates a high 361 
sensitivity to most beta-lactam antibiotics considered except for cloxacillin and 362 
nafcillin. As for tetracyclines the Charm MRL BLTET test was also able to detect 363 
chlortetracycline, oxytetracycline, tetracycline and 4-epioxytetracycline at or below EU-364 
MRL. Acidiol had no effect on the performance of the test. 365 
The great performance characteristics of the Charm MRL BLTET test makes it suitable 366 
to be included in ewe's and goat's milk quality programs as a fast routine method on 367 
farms and in the dairy industries. 368 
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Table 1. Antimicrobials used to evaluate the Charm MRL BLTET test in ewe’s and 
goat’s milk 
Antimicrobials Distributor 
Commercial 
reference 
Solvent 
Aminoglycosids    
Neomycin Sigma-Aldrich
1
 N1876 H2O 
Beta-lactams    
Amoxicillin Sigma-Aldrich A8523 H2O 
Ampicillin Sigma-Aldrich A9518 H2O 
Benzylpenicillin Sigma-Aldrich PENNA H2O 
Cloxacillin Sigma-Aldrich C9393 H2O 
Dicloxacillin Sigma-Aldrich D9016 MeOH / H20 
Nafcilin Sigma-Aldrich N3269 MeOH / H20 
Oxacillin Sigma-Aldrich 46589 MeOH / H20 
Cefacetrile Fatro
2
 * H2O 
Cefalonium Sigma-Aldrich 32904 NaOH 0.1N /H2O 
Cefapirin Sigma-Aldrich 43989 H2O 
Desacetylcefapirin ACS Dobfar
3
 * H2O 
Cefazolin Sigma-Aldrich C5020 H2O 
Cefoperazone Sigma-Aldrich 32426 NaOH 1N / H2O 
Cefquinome Sigma-Aldrich 32472 H2O 
Ceftiofur Sigma-Aldrich 34001 NaOH 0.1N / H2O 
Desfuroylceftiofur TRC
4
 D289980 MeOH / H20 
Cephalexin Sigma-Aldrich C4895 H2O 
Lincosamides    
Lincomycin Sigma-Aldrich 31727 H2O 
Macrolides    
Erythromycin Sigma-Aldrich E6376 EtOH / H20 
Polimyxins    
Colistin Sigma-Aldrich C4461 H2O 
Quinolones    
Enrofloxacin Sigma-Aldrich 33699 AcOH 5% / H20 
Sulfonamides    
Sulfadiazine Sigma-Aldrich S6387 H2O 
Tetracyclines    
Chlortetracycline Sigma-Aldrich C4881 NaOH 0.1N / H2O 
4-epichlortetracycline Acros
5
 268235000 MeOH / H20 
Oxytetracycline Sigma-Aldrich O4636 HCl 0.1N / H2O 
4-epioxytetracycline Acros 25771 MeOH / H20 
Tetracycline Sigma-Aldrich T3258 HCl 0.1N / H2O 
4-epitetracycline Acros 233125000 MeOH / H20 
1
Sigma-Aldrich Química, S.A. (Madrid, Spain) 
2
Fatro, S.p.A. (Bologna, Italy) 
3
ACS Dobfar, S.p.A. (Milan, Italy) 
4
Toronto Research Chemicals, Inc. (Toronto, Canada) 
5
Acros Organics (Geel, Belgium) 
*Commercial reference not available 
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Table 2. Quality parameters of ewe’s and goat’s milk samples obtained along the entire lactation 
period 
1 
SD: standard deviation; 
2 
Min: minimum;
 3 
Max: maximum; 
4 
BC: bacterial count; 
5 
SCC: somatic cell 
count 
Parameter 
Ewe’s milk 
(n= 250) 
Goat’s milk 
(n= 350) 
Average SD
1
 Min
2
 Max
3
 Average SD
1
 Min
2
 Max
3
 
pH 6.67 0.08 6.52 6.92 6.78 0.09 6.55 7.13 
Fat (%) 6.38 1.94 2.42 12.68 5.74 1.16 3.31 10.61 
Protein (%) 5.81 0.72 4.55 7.82 3.82 0.48 2.68 6.03 
Total solids (%) 18.02 2.54 12.51 26.53 15.0 1.51 12.13 20.48 
BC
4
 (x10
3
 cfu.mL
-1
) 566 1,508 6 9,999 74 306 10 4,829 
SCC
5
 (x10
3
 cell.mL
-1
) 687 2,667 10 20,581 975 1,737 37 16,837 
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Table 3. Specificity (false-positive rate) of the Charm MRL BLTET test in antibiotic-free 
milk from ewes and goats with adapted test procedure 
 
Milk samples 
Test 
line 
Results 
Visual Instrumental 
P Q N S (%) P N S (%) 
Ewes 
(n = 250) 
BL 2 1 247 98.8 2 248 99.2 
TET 0 0 250 100 0 250 100 
Goats 
(n = 350) 
BL 7 2 341 97.4 7 343 97.9 
TET 0 1 349 99.7 0 350 100 
P: positive, Q: questionable, N: negative, S (%): Specificity = negatives/total x 100 
23 
 
Table 4. Detection capability (CCβ values) of the Charm MRL BLTET test for 
antibiotics in ewe’s milk with adapted test procedure 
 
1
STC: Screening Target Concentration 
2
According to the CRLs (2010) STC = 0.5xEU-MRL: 20 samples; STC = 0.75xEU-MRL: 40 samples; 
STC = 1xEU-MRL: 60 samples 
3
sum of cefapirin and desacetylcefapirin 
4
sum of all residues retaining the beta-lactam structure expressed as desfuroylceftiofur 
5
sum of parent drug and its 4-epimer 
*marker residue. EU-MRL not established 
 
Antimicrobials  
EU-MRL 
(µg.Kg
-1
) 
STC
1
 
(µg.Kg
-1
) 
Positive/Total 
samples
2
 
Positive 
Results 
(%) 
CCβ 
(µg.Kg
-1
) 
Beta-lactams      
Amoxicillin 4 4 57/60 95 4 
Ampicillin 4 4 58/60 97 4 
Benzylpenicillin 4 2 19/20 95 ≤ 2 
Cloxacillin 30 30 11/60 18 > 30 
Dicloxacillin 30 30 57/60 95 30 
Nafcilin 30 30 22/60 37 > 30 
Oxacillin 30 30 59/60 98 30 
Cefacetrile 125 63 20/20 100 ≤ 63 
Cefalonium 20 10 20/20 100 ≤ 10 
Cefapirin 60
3
 30 20/20 100 ≤ 30 
Desacetylcefapirin * 30 20/20 100 ≤ 30 
Cefazolin 50 25 20/20 100 ≤ 25 
Cefoperazone 50 25 20/20 100 ≤ 25 
Cefquinome 20 20 60/60 100 20 
Ceftiofur 100
4
 50 20/20 100 ≤ 50 
Desfuroylceftiofur * 50 20/20 100 ≤ 50 
Cephalexin 100 50 20/20 100 ≤ 50 
Tetracyclines      
Chlortetracycline 100
5
 50 20/20 100 ≤ 50 
4-epichlortetracycline * 100 0/60 0 > 100 
Oxytetracycline 100
5
 50 20/20 100 ≤ 50 
4-epioxytetracycline * 75 40/40 100 75 
Tetracycline 100
5
 50 20/20 100 ≤ 50 
4-epitetracycline * 100 0/60 0 > 100 
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Table 5. Detection capability (CCβ values) of the Charm MRL BLTET test for antibiotics 
in goat’s milk with adapted test procedure 
1
STC: Screening Target Concentration 
2
According to the CRLs (2010) STC = 0.5xEU-MRL: 20 samples; STC = 0.75xEU-MRL: 40 samples; 
STC = 1xEU-MRL: 60 samples 
3
sum of cefapirin and desacetylcefapirin 
4
sum of all residues retaining the beta-lactam structure expressed as desfuroylceftiofur 
5
sum of parent drug and its 4-epimer 
*marker residue. EU-MRL not established 
 
Antimicrobials  
EU-MRL 
(µg.Kg
-1
) 
STC
1
 
(µg.Kg
-1
) 
Positive/Total 
samples
2
 
Positive 
Results 
(%) 
CCβ 
(µg.Kg
-1
) 
Beta-lactams      
Amoxicillin 4 4 57/60 95 4 
Ampicillin 4 4 58/60 97 4 
Benzylpenicillin 4 2 20/20 100 ≤ 2 
Cloxacillin 30 30 9/60 15 > 30 
Dicloxacillin 30 30 58/60 97 30 
Nafcillin 30 30 18/60 30 > 30 
Oxacillin 30 30 60/60 100 30 
Cefacetrile 125 63 20/20 100 ≤ 63 
Cefalonium 20 10 20/20 100 ≤ 10 
Cefapirin 60
3
 30 20/20 100 ≤ 30 
Desacetylcefapirin * 30 20/20 100 ≤ 30 
Cefazolin 50 25 20/20 100 ≤ 25 
Cefoperazone 50 25 20/20 100 ≤ 25 
Cefquinome 20 20 60/60 100 20 
Ceftiofur 100
4
 50 20/20 100 ≤ 50 
Desfuroylceftiofur * 50 20/20 100 ≤ 50 
Cephalexin 100 50 20/20 100 ≤ 50 
Tetracyclines      
Chlortetracycline 100
5
 75 38/40 95 75 
4-epichlortetracycline * 100 0/60 0 > 100 
Oxytetracycline 100
5
 50 20/20 100 ≤ 50 
4-epioxytetracycline * 50 20/20 100 ≤ 50 
Tetracycline 100
5
 50 19/20 95 ≤ 50 
4-epitetracycline * 100 8/60 13 > 100 
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Figure 1. Effect of acidiol in ewe’s and goat’s milk samples on the results of the Charm 
MRL BLTET test 
 
 
 
 
 
